Implants for the treatment of dopamine associated states
作者： Steven J. Siegel , Terri B. Sebree
DOI:
关键词: Pharmacology 、 Dopamine 、 Biodegradable implants 、 Biocompatible material 、 Biodegradable polymer 、 Chemistry
摘要: Biodegradable implants comprising dopamine modulating compounds are described. In particular, biodegradable for use in treating a subject associated states, the biocompatible and/or polymers and compounds, such as agonists,
google.nl 参考文章(38)
Barbara S Apgar, M.H.S.A. Grant M Greenberg, Using progestins in clinical practice. American Family Physician. ,vol. 62, pp. 1839- 1846 ,(2000)
Thierry Nivaggioli, Jane Guo Shiah, Qing Lin, Biodegradable ocular implants with long-term release characteristics ,(2005)
Nicole Nihant, Chantal Schugens, Christian Grandfils, Robert Jérôme, Philippe Teyssié, Polylactide Microparticles Prepared by Double Emulsion/Evaporation Technique. I. Effect of Primary Emulsion Stability Pharmaceutical Research. ,vol. 11, pp. 1479- 1484 ,(1994) , 10.1023/A:1018912426983
Ian Tulloch, Novel therapeutic method ,(2001)
Luping No. Dongfang Huayuan Zhang, Long acting sustained-release formulation containing dopamine receptor agonist and the preparation method thereof ,(2005)
David A. A. Owen, Treatment of Parkinsons disease ,(1988)
Frédéric Heimgartner, Robert Gurny, Alexandra Rothen-Weinhold, Piero Orsolini, Implants for controlled release of pharmaceutically active principles and method for making same ,(1998)
Herbert Stricker, Otto Kern, Gunther Entenmann, Michel Mikhail, Bernd Zierenberg, Implantable, biodegradable system for releasing active substance ,(1995)
Mohamad D. Shalati, Kallidaikurichi N. Sivaramakrishnan, Controlled release delivery system for macromolecules ,(1986)
Laurence Tecott, Jack D. Barchas, James Eberwine, In situ transcription in cells and tissues ,(1988)